Rojas, Magdalena C.

HRN: 00-21-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/12/2026
03/12/2026
IV
1g
Now
Fracture Closed Femoral Neck Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: